Zachary Scheiner's most recent trade in SpyGlass Pharma Inc. was a trade of 27,400 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SpyGlass Pharma Inc | Zachary Scheiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 27,400 | 27,400 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc | Zachary Scheiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Zachary Scheiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 46,000 | 46,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Zachary Scheiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc | Zachary Scheiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Zachary Scheiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Zachary Scheiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Zachary Scheiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2021 | 16,511 | 16,511 | - | - | Stock Option (right to buy) |